Co-Diagnostics ROE 2017-2024 | CODX

Current and historical return on equity (ROE) values for Co-Diagnostics (CODX) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Co-Diagnostics ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-09-30 $-0.04B $0.06B -56.00%
2024-06-30 $-0.04B $0.07B -45.37%
2024-03-31 $-0.04B $0.08B -42.62%
2023-12-31 $-0.04B $0.09B -36.09%
2023-09-30 $-0.04B $0.10B -40.19%
2023-06-30 $-0.04B $0.10B -32.76%
2023-03-31 $-0.03B $0.11B -25.35%
2022-12-31 $-0.01B $0.12B -10.33%
2022-09-30 $0.02B $0.14B 10.70%
2022-06-30 $0.03B $0.14B 20.53%
2022-03-31 $0.04B $0.15B 34.12%
2021-12-31 $0.04B $0.13B 36.27%
2021-09-30 $0.04B $0.10B 50.91%
2021-06-30 $0.05B $0.09B 66.43%
2021-03-31 $0.05B $0.08B 89.66%
2020-12-31 $0.04B $0.07B 98.29%
2020-09-30 $0.03B $0.05B 101.82%
2020-06-30 $0.01B $0.04B 66.67%
2020-03-31 $-0.01B $0.02B -82.76%
2019-12-31 $-0.01B $0.00B -150.00%
2019-09-30 $-0.01B $0.00B -184.62%
2019-06-30 $-0.01B $0.01B -240.00%
2019-03-31 $-0.01B $0.01B -400.00%
2018-12-31 $-0.01B $-0.00B -800.00%
2018-09-30 $-0.01B $0.00B -300.00%
2018-06-30 $-0.01B $0.00B -246.15%
2018-03-31 $-0.01B $0.00B -400.00%
2017-12-31 $-0.01B $0.00B -640.00%
2017-06-30 $-0.00B $-0.00B 200.00%
2017-03-31 $-0.00B $0.00B inf%
Sector Industry Market Cap Revenue
Medical Medical Services $0.022B $0.007B
Co-Diagnostics Inc. is a molecular diagnostics company. It develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company's technology is utilized for tests which are designed using the detection and/or analysis of nucleic acid molecules. It also uses proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers. Co-Diagnostics Inc. is based in UT, United States.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $151.685B 28.04
Elevance Health (ELV) United States $90.559B 11.84
Cencora (COR) United States $47.572B 17.32
Natera (NTRA) United States $23.122B 0.00
DiDi Global (DIDIY) China $22.844B 0.00
ICON (ICLR) Ireland $16.164B 14.40
Avantor (AVTR) United States $14.769B 22.14
Revvity (RVTY) United States $14.502B 24.32
BioMerieux (BMXMF) France $14.256B 0.00
Viatris (VTRS) United States $13.010B 4.01
Solventum (SOLV) United States $12.919B 0.00
CochLear (CHEOY) Australia $12.848B 0.00
Medpace Holdings (MEDP) United States $11.220B 31.61
Doximity (DOCS) United States $10.877B 56.56
EUROFINS SCIENT (ERFSF) Luxembourg $10.037B 0.00
HealthEquity (HQY) United States $9.712B 48.73
Sonic Healthcare (SKHHY) Australia $8.513B 0.00
Charles River Laboratories (CRL) United States $8.502B 16.43
Amplifon S.p.A (AMFPF) Italy $6.136B 31.28
Bausch + Lomb (BLCO) Canada $5.661B 26.33
BrightSpring Health Services (BTSG) United States $3.913B 83.22
Sotera Health (SHC) United States $3.909B 20.91
Organon (OGN) United States $3.835B 3.87
Surgery Partners (SGRY) United States $3.260B 37.17
Concentras Parent (CON) United States $2.958B 0.00
Alignment Healthcare (ALHC) United States $2.885B 0.00
PACS (PACS) United States $2.161B 0.00
Ardent Health Partners (ARDT) United States $2.121B 0.00
Teladoc Health (TDOC) United States $2.061B 0.00
Progyny (PGNY) United States $1.859B 37.64
GoodRx Holdings (GDRX) United States $1.837B 48.20
Premier (PINC) United States $1.821B 11.08
GeneDx Holdings (WGS) United States $1.708B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.409B 0.00
Agilon Health (AGL) United States $1.351B 0.00
CareDx (CDNA) United States $1.217B 0.00
Pediatrix Medical (MD) United States $1.177B 11.51
Embecta (EMBC) United States $1.031B 7.06
AMN Healthcare Services Inc (AMN) United States $0.993B 6.72
Establishment Labs Holdings (ESTA) $0.848B 0.00
Auna S.A (AUNA) Luxembourg $0.602B 0.00
SBC Medicals (SBC) United States $0.533B 0.00
DocGo (DCGO) United States $0.501B 18.89
Sonida Senior Living (SNDA) United States $0.464B 0.00
InnovAge Holding (INNV) United States $0.435B 0.00
Enhabit (EHAB) United States $0.414B 35.83
QDM (QDMI) Hong Kong, SAR China $0.382B 10.00
MultiPlan (MPLN) United States $0.352B 0.00
Nutex Health (NUTX) United States $0.323B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.317B 0.00
LifeMD (LFMD) United States $0.270B 0.00
Beauty Health (SKIN) United States $0.201B 0.00
Performant Healthcare (PHLT) United States $0.185B 0.00
Sera Prognostics (SERA) United States $0.159B 0.00
Biodesix (BDSX) United States $0.151B 0.00
So-Young (SY) China $0.104B 17.63
Ascend Wellness Holdings (AAWH) United States $0.086B 0.00
IceCure Medical (ICCM) Israel $0.072B 0.00
Oncology Institute (TOI) United States $0.067B 0.00
ModivCare (MODV) United States $0.062B 3.35
NeueHealth (NEUE) United States $0.061B 1.61
Singular Genomics Systems (OMIC) United States $0.050B 0.00
OncoCyte (OCX) United States $0.035B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.031B 0.00
Pheton Holdings (PTHL) China $0.019B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.009B 0.00
KindlyMD (KDLY) United States $0.007B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
XWELL (XWEL) United States $0.006B 0.00
Aclarion (ACON) United States $0.003B 0.00
ISpecimen (ISPC) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00